| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/03/2013 | CN103012575A Low-temperature and drought resistant gene AtLTP3 (lipid Transfer Protein3) of plant, protein coded by gene and application of gene |
| 04/03/2013 | CN103012574A Low-phosphor stress response regulatory factor ZmPHR1, gene for coding the protein and application |
| 04/03/2013 | CN103012573A Tobacco JAZ protein as well as gene and application thereof |
| 04/03/2013 | CN103012572A Gene capable of reducing nicotine content of tobacco and application thereof |
| 04/03/2013 | CN103012571A Gene capable of reducing nicotine content of tobacco and application thereof |
| 04/03/2013 | CN103012570A Plant adverse resistance related protein PpLEA3-21 and coding gene and application thereof |
| 04/03/2013 | CN103012569A Alpha-amylase repressor SbAAI1 gene and protein as well as application of gene |
| 04/03/2013 | CN103012568A Methicillin-resistant staphylococcus aureus (MRSA) vaccine recombinant protein FnbA1 and preparation method and application thereof |
| 04/03/2013 | CN103012567A Amino acid sequence for detecting drug-resistant protein inhibiting factors |
| 04/03/2013 | CN103012566A Non-phosphorylation ligand combined with Grb7 protein SH2 structural domain and pharmaceutical application thereof |
| 04/03/2013 | CN103012470A Method for preparing liquid phytic acid from rapeseed dregs |
| 04/03/2013 | CN103012193A Malachite green hapten, malachite green artificial antigen and preparation method of malachite green hapten and artificial antigen |
| 04/03/2013 | CN102268079B (Classical swine fever virus) CSFV E2 protein ligand epitope peptide and application thereof |
| 04/03/2013 | CN102180966B Method for producing human alpha1-antitrypsin in large scale |
| 04/03/2013 | CN102174097B Actinoporin and application thereof |
| 04/03/2013 | CN102146126B Protein related to insect resistance and encoding gene and application thereof |
| 04/03/2013 | CN102127159B Plant light energy conversion efficiency associated protein and encoding gene and application thereof |
| 04/03/2013 | CN102120765B Method for synthetizing basic orange II artificial antigen |
| 04/03/2013 | CN101993482B Protein associated with long grain foliaceous of paddy rice and coding gene and application thereof |
| 04/03/2013 | CN101914149B Preparation and application of anti-lipid polysaccharide factor with bacteriostatic activity |
| 04/03/2013 | CN101899100B Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof |
| 04/03/2013 | CN101805403B aurification method of prokaryotic expression Arresten protein |
| 04/03/2013 | CN101759781B Protein adhered to surface layers of bacteria and application thereof |
| 04/03/2013 | CN101426814B Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/03/2013 | CN101356265B Productivity augmenting protein factor, novel cell lines and uses thereof |
| 04/03/2013 | CN101351224B Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
| 04/03/2013 | CN101282990B Method for preparing glycosylated interferon-beta |
| 04/03/2013 | CN101046478B Method for detecting n-terminal pre-BNP |
| 04/02/2013 | US8410253 Scavenger receptor |
| 04/02/2013 | US8410252 ULBP2 polypeptides |
| 04/02/2013 | US8410248 HWBAO62 polypeptides |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8410060 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 04/02/2013 | US8410052 Oral administration of a calcitonin |
| 04/02/2013 | US8410051 FGF21 mutants and uses thereof |
| 04/02/2013 | US8410048 Method for producing insulin analogs having a dibasic B chain terminus |
| 04/02/2013 | US8410045 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 04/02/2013 | US8409857 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 04/02/2013 | US8409842 Recombinant adeno-associated virus production |
| 04/02/2013 | US8409836 Treatment of cellulosic material and enzymes useful therein |
| 04/02/2013 | US8409828 Animal product free system and process for purifying a botulinum toxin |
| 04/02/2013 | US8409815 sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases |
| 04/02/2013 | US8409814 Sensor proteins and assay methods |
| 04/02/2013 | US8409812 Annexin A3 for cancer diagnosis |
| 04/02/2013 | US8409622 Process for manufacturing biocompatible material |
| 04/02/2013 | US8409589 Mutant forms of streptolysin O |
| 04/02/2013 | US8409582 Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods |
| 04/02/2013 | US8409579 Humanized anti-FGF19 antagonists and methods using same |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | CA2681317C A synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| 04/02/2013 | CA2581110C Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2546498C Peptide increasing fusiogenic capacity of a gamete |
| 04/02/2013 | CA2531441C Hybrid toxins comprising shiga or shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 04/02/2013 | CA2502948C Modified bio-related substance, process for producing the same, and intermediate |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2460392C Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity |
| 04/02/2013 | CA2453062C Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 04/02/2013 | CA2425794C Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 04/02/2013 | CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/28/2013 | WO2013044225A1 A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens |
| 03/28/2013 | WO2013044164A1 Methods to treat and/or prevent relapse in notch1-driven malignancies |
| 03/28/2013 | WO2013043870A1 Compositions and methods related to tissue targeting |
| 03/28/2013 | WO2013043720A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | WO2013043669A1 Peptoid compositions for the treatment of alzheimer's disease and polyglutamine expansion disorder |
| 03/28/2013 | WO2013043516A1 Mdl-1 ligand |
| 03/28/2013 | WO2013043071A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | WO2013043013A2 Composition containing complex cytokines derived from ebv-infected b cells for inducing the maturation of dendritic cells |
| 03/28/2013 | WO2013042868A1 Method of obtaining silkworm gland-derived hydrolysate |
| 03/28/2013 | WO2013042156A2 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 03/28/2013 | WO2013042129A1 Improved process for preparation of bivalirudin |
| 03/28/2013 | WO2013042120A2 Synthetic ubiquitins and use thereof in drug screening assays |
| 03/28/2013 | WO2013041962A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 03/28/2013 | WO2013041961A1 Cell culture substrate comprising a laminin and a cadherin |
| 03/28/2013 | WO2013041925A1 Methods and compositions for characterizing phenotypes using kinome analysis |
| 03/28/2013 | WO2013041865A1 T cell receptors |
| 03/28/2013 | WO2013041843A1 Cell differentiation |
| 03/28/2013 | WO2013041730A1 Serum half-life extension using immunoglobulin binding domains |
| 03/28/2013 | WO2013041726A1 A human epithelial cell line for 3d -modelizing of cancer and treatment thereof |
| 03/28/2013 | WO2013041725A1 Fibroblasts cellular model for assessing efficacy of cancer treatments by SHH/PTCH pathway antagonists |
| 03/28/2013 | WO2013041724A1 Human keratinocytes ptch1 cell line |
| 03/28/2013 | WO2013041678A1 Novel glucagon analogues |
| 03/28/2013 | WO2013041588A1 A method of detecting active tb |
| 03/28/2013 | WO2013041487A1 Co2 profile cultivation |
| 03/28/2013 | WO2013041239A1 Pkm zeta bindin peptides, peptide derivatives and conjugates, and uses thereof |
| 03/28/2013 | WO2013041238A1 Use of kibra peptides, hdac inhibitor or proteasome inhibitor for improving anxiety disorders |
| 03/28/2013 | WO2013041237A2 Methods for identifying compounds capable of inhibiting degradation of pkm zeta |
| 03/28/2013 | WO2013041223A1 Crystal structure of the 60s eukaryotic ribosomal subunit and its uses |
| 03/28/2013 | WO2013041029A1 Novel soluble ctla4 variants |
| 03/28/2013 | WO2013040766A1 Method and vaccine capable of inducing broad spectrum immune response against hiv |
| 03/28/2013 | WO2013016428A9 Recombinant apoa-1m from engineered bacteria |
| 03/28/2013 | WO2012176138A3 Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine |
| 03/28/2013 | WO2012175672A3 Diagnosis and/or prognosis of parkinson's disease dementia |
| 03/28/2013 | WO2012153196A3 Glu-glp-1 dual agonist signaling-selective compounds |
| 03/28/2013 | WO2012076157A3 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 03/28/2013 | WO2010141918A9 Serum amyloid p derivatives and their preparation and use |